Management Team

The C4X Discovery management team has significant drug discovery and development expertise and experience, with a track record of value creation.

Clive Dix, PhD

Chief Executive Officer (Director)
  • Serially successful biotech entrepreneur
  • Exits include Convergence Pharmaceuticals (2015) and PowderMed Ltd (2006)
  • Ex UK Research Director, GlaxoWellcome
  • Former BIA Chairman

Craig Fox, PhD

Chief Scientific Officer (Director)
  • 18 years’ drug discovery experience from target selection to Phase 2 clinical studies
  • Previously Director of Respiratory Research at Pulmagen Therapeutics, Argenta
  • Managed several collaborations and partnerships at Pulmagen, including those with AstraZeneca, Chiesi, Domantis, Dr Reddy’s, SkyePharma and Teijin Pharma
  • Ex Bayer Pharmaceuticals

Brad Hoy

Chief Financial Officer (Director)
  • More than 20 years’ experience in the pharmaceutical and biotechnology industries
  • Previously Chief Financial Officer of Plethora Solutions Holdings plc, Chief Executive Officer of Xcellsyz Limited, and Senior Director of Geron Corporation’s stem-cell focused UK subsidiary
  • Co-founder of Seven Hills Venture Partners and serves on the Board of Directors for e-Therapeutics plc.

Bhavna Hunjan

Corporate Strategy
  • 10 years’ experience across investment banking and strategic consultancy, providing commercial advice including business strategy, deal structuring and execution, product positioning, portfolio reviews, and regulatory change
  • Previously Senior Strategist at Cancer Research UK
  • Ex Lehman Brothers, Nomura International plc, and PricewaterhouseCoopers